Clinical course · draft
Therapeutic plasmapheresis
A draft clinical course on therapeutic plasmapheresis: what it is, the evidence status, indications, safety, adverse events and consent, with sources. Includes onsite training, 2 days.
Curriculum
Understanding the treatment
- What it is and the evidence statusReading
- Recognised indicationsReading
Delivering safely
- Contraindications and pre-treatment checksReading
- Safety protocol and monitoringReading
- Adverse events and escalationReading
- Consent pointsReading
Onsite training
- Onsite trainingOnsite
References
- SourcesReading · free preview
References
Sources
- Connelly-Smith L et al. Guidelines on the use of therapeutic apheresis in clinical practice: the ninth special issue. J Clin Apher. 2023;38:77-278.
- Boada M et al. A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: primary results of the AMBAR study. Alzheimers Dement. 2020.
- Feasibility, safety, and tolerability of two modalities of plasma exchange with albumin replacement in the AMBAR study.
- FDA. Important information about young donor plasma infusions for profit. 2019.
- de Back DZ, Neyrinck MM, Vrielink H. Therapeutic plasma apheresis: expertise and indications.
- Risk of hypotensive reactions is increased when using partial saline replacement for therapeutic plasma exchange. J Clin Apher. 2019.